Few pharmacological options available for treating cognitive impairment associated with severe Alzheimer's disease

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.10, 2009-10, pp. : 9-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological treatment in moderate-to-severe Alzheimer's disease

By Hsiung Ging-Yuek Robin Feldman Howard H

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2575-2582

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease

Current Psychopharmacology, Vol. 3, Iss. 1, 2014-04 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies

By Radanovic Marcia Pereira Fabrício Ramos Silvestre Stella Florindo Aprahamian Ivan Ferreira Luiz Kobuti Forlenza Orestes Vicente Busatto Geraldo F

Expert Review of Neurotherapeutics, Vol. 13, Iss. 5, 2013-05 ,pp. : 483-493

Informa Healthcare

Access to resources Recommend Favorite

The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimer's Disease

By Cappell Jaclyn Herrmann Nathan Cornish Stephen Lanctôt Krista L.

CNS Drugs, Vol. 24, Iss. 11, 2010-11 ,pp. : 909-927

Adis International

Access to resources Recommend Favorite

Consider the benefits and limitations of the available options when treating gastro-oesophageal reflux disease

Drugs & Therapy Perspectives, Vol. 28, Iss. 7, 2012-07 ,pp. : 14-16

Adis International

Access to resources Recommend Favorite